Medical Director, Neuro-Oncology (Phase 3) – Hybrid

Servier Pharmaceuticals; Boston (MA); Hybrid; USD 250,000 - 316,000; Full time

Benefits offered by this job

Incentive programs

Benefits package

401(k)

Job summary

Servier is seeking a Medical Director to serve as Medical Monitor for Phase 3 registration-enabling studies within the Neuro Oncology portfolio. The role will support late-stage execution, patient safety, data quality, protocol implementation, investigator engagement, and regulatory interactions.

The position is hybrid in Boston, MA, or remote within the United States, with anticipated travel 10–20%. The candidate will provide medical oversight, mentor teams, and contribute to protocol

Qualifications

• MD required with specialty training and board certification in Medical Oncology or Neuro-Oncology.
• 2 or more years in clinical trial experience, industry or academic setting.
• Excellent public speaking, writing, and communication skills; ability to mentor and work cross-functionally.

Responsibilities

• Provide medical oversight for clinical activities on assigned studies, including study execution, regulatory interactions, and safety monitoring.
• Develop and lead presentations for governance meetings to support timely decisions.
• Mentor the clinical scientist function and provide disease-area expertise.

Skills

Medical Oncology

Communication skills

Public speaking

Cross-functional collaboration

Mentoring

Problem solving

Education

MD in Medical Oncology or Neuro-Oncology

2+ years clinical trials experience

Job description

Servier is seeking a Medical Director to serve as Medical Monitor for Phase 3 registration-enabling studies within the Neuro Oncology portfolio. The role will support late-stage execution, patient safety, data quality, protocol implementation, investigator engagement, and regulatory interactions.

The position is hybrid in Boston, MA, or remote within the United States, with anticipated travel 10–20%. The candidate will provide medical oversight, mentor teams, and contribute to protocol